Health
New targets for the development of a drug treatment for obesity and type 2 diabetes – Medical Xpress
The GIP receptor in the central nervous system plays a crucial role in the regulation of body weight and food intake. This is shown by a recent study by Helmholtz…
The GIP receptor in the central nervous system plays a crucial role in the regulation of body weight and food intake. This is shown by a recent study by Helmholtz Zentrum München, ETH Zurich and the German Center for Diabetes Research (DZD). The study, which has now been published in Cell Metabolism, identifies new targets for the development of a drug treatment for obesity and type 2 diabetes.
Dual-agonists targeting the receptors for Glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic…
-
General18 hours agoGymnastics club in Berwick shuts down following child safety complaint
-
General23 hours agoCritically endangered orchid thrives as NSW Mid North Coast cemetery provides habitat refuge
-
Noosa News21 hours agoSanta drops in for carols
-
Business23 hours agoThe best Australian stock you’ve never heard of